Effect of metergoline, a specific serotonin antagonist, on human growth hormone response to arginine and L-dopa

Horm Metab Res. 1976 Mar;8(2):106-8. doi: 10.1055/s-0028-1093682.

Abstract

In seven normal subjects the repeated oral administration of metergoline, a specific antiserotonin agent, has enhanced HGH response to arginine infusion. Following placebo administration, arginine-induced HGH release was slightly but not significantly reduced; similarly, in eight metergoline treated subjects, HGH response to oral L-Dopa was slightly but not significantly reduced. HGH response to i.v. L-Dopa was not modified by the drug. These results suggest that serotonin controls HGH response only in response to arginine, not to L-Dopa.

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Adolescent
  • Adult
  • Arginine / pharmacology*
  • Dihydroxyphenylalanine / pharmacology
  • Ergolines / pharmacology*
  • Female
  • Growth Hormone / blood*
  • Humans
  • Male
  • Metergoline / pharmacology*
  • Middle Aged
  • Serotonin Antagonists*

Substances

  • Ergolines
  • Serotonin Antagonists
  • Metergoline
  • Dihydroxyphenylalanine
  • Growth Hormone
  • Arginine